Parkwood »

ImmunoGen shares owned by Parkwood

Quarter-by-quarter ownership of ImmunoGen shares owned by Parkwood from 13F filings

Historical chart of Parkwood investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Parkwood consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Parkwood

Quarter filed Position value Share count Share price at filing
2023-12-31 $766k 26k 29.66
2022-09-30 $249k 52k 4.79
2022-03-31 $368k 77k 4.76
2021-06-30 $428k 65k 6.59
2017-06-30 $89k 13k 7.13

More positions owned by Parkwood

Vanguard Total Stock Mkt Etf Etp (VTI)
Ishares Russell 2000 Etf Etp (IWM)
Spdr S&p 500 Etf Trust Etp Put Option (SPY)
Spdr Bloomberg 1-3 Month T-b Etp (BIL)
Ishares 20 Year Treasury Bo Etp Call Option (TLT)
Novo-nordisk A/s-spons Adr (NVO)
Meta Platforms Inc-class A Common Stock (META)
Elevance Health Common Stock (ELV)
Nvidia Corp Common Stock (NVDA)
Vanguard Tot World Stk Etf Etp (VT)
Uber Technologies Common Stock (UBER)
Microsoft Corp Common Stock (MSFT)
Canadian Natural Resources Common Stock (CNQ)
Visa Inc-class A Shares Common Stock (V)
Advanced Micro Devices Common Stock (AMD)

View all positions for Parkwood

Top funds holding ImmunoGen

Wellington Management Company
Healthcare Of Ontario Pension Plan Trust Fund
Alliancebernstein
venBio Select Advisor
Decheng Capital
Hsbc Holdings
PRIMECAP Management Company
Allianz Asset Management
DLD Asset Management
Nicholas Investments Partners
MetLife Investment Advisors
American International
Guggenheim Capital, LLC Managers
Angelo, Gordon & Co
Kellner Capital

View all funds holding ImmunoGen